TrialArthritis research & therapy2022

The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies.

Clifton O Bingham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.